Clinical Trial Update: The Prognostic Value of PGF and sFlt1 Variations Induced by the First Low-molecular-weight-heparin Injections in Women With Obstetrical Antiphospholipids Antibody Syndrome Starting a New Pregnancy and Following Treatment in Accordance With International Recommendations

View source ↗

Summary

A completed clinical trial studied the prognostic value of PGF and sFlt1 biomarker variations induced by initial low-molecular-weight heparin injections in preg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Antiphospholipid Syndrome | Status: COMPLETED